Comera Life Sciences Holdings, Inc. Deferred Revenue
Comera Life Sciences Holdings, Inc. had Deferred Revenue of $36.31 thousand as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-11-09
- 2023-06-30: Deferred Revenue, Current $36.31K.
- 2022-12-31: Deferred Revenue, Current $144.28K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-06-30 | $36.31K 10-Q · filed 2023-08-10 |
| 2022-12-31 | $144.28K 10-Q · filed 2023-11-09 |